Satisfaction. For you and your patients.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | July 8, 2022

Before the onset of the coronavirus pandemic, forces at the federal level were in motion to transform the healthcare industry from a closed to a more open system.

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.

whitePaper | March 10, 2023

The healthcare industry has widely acknowledged that the more we understand a patient’s unique healthcare journey the greater the chance we have at a positive health outcome. How does that concept tie in to real-word data (RWD)?

whitePaper | September 27, 2021

Employer wellness programs are supposed to reduce healthcare costs, but many are failing because they focus on the wrong benchmarks. To create lasting change, wellness programs need to combine data insights with actionable steps.

whitePaper | September 12, 2022

While informed consent is a critical process for ensuring participant autonomy in clinical research, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels.